Challenge Awards from the PhRMA Foundation support trainees by recognizing research articles and minireviews on advanced therapeutics to advance understanding of drug disposition and translational pharmacology.
Funder: PhRMA Foundation
Due Dates: February 1, 2027 (Advanced Modalities paper submission)
Funding Amounts: $5,000 to the first author of each of up to five winning papers
Summary: The current Challenge Award recognizes outstanding trainee papers on advanced therapeutic modalities in Drug Metabolism and Disposition.
Key Information: First authors must be trainees; pharmaceutical company employees may compete but cannot receive award money.
The PhRMA Foundation’s Challenge Awards recognize papers and research proposals addressing pressing questions in research and health care. For the current competition, the Foundation is partnering with ASPET’s journal Drug Metabolism and Disposition (DMD) to recognize outstanding trainee papers in a special issue on “Advanced Modalities in Drug Development: Radiopharmaceuticals, ADCs, Delivery Systems and Biodistribution of Next-Generation Gene and Cell Therapies.”
The call seeks original research articles and minireviews advancing understanding of absorption, distribution, metabolism, and excretion (ADME), biodistribution, and translational pharmacology of emerging therapeutics. It aims to connect advanced molecular engineering with translational ADME science, emphasizing mechanisms of disposition, pharmacokinetic/pharmacodynamic relationships, bioanalytical methods, and safety. Contributions addressing preclinical-to-clinical translation, innovative animal models, mechanistic disposition studies, and safety considerations are particularly encouraged.